Theodore Shou, CEO of Yiyi Capital, discusses the recent strong performance of the IPO market in Hong Kong and says that the valuation premium between mainland China and Hong Kong stocks would narrow ...

H-shares as a whole still trade at a discount of 32% to A-shares, compared with a low of 28% in March, according to the Hang ...

Chinese drug developer Jiangsu Hengrui Pharmaceuticals has priced its stock offering on the Hong Kong Stock Exchange at HK$44 ...

CATL, which produces more than a third of all electric vehicle batteries sold worldwide, raised US$4.6 billion in Hong Kong.

Shares of Chinese companies Jiangsu Hengrui Pharmaceuticals and Mirxes Holdings rose sharply on Friday in Hong Kong trading debuts after raising a combined $1.4 billion in separate listings.

Shanghai Futures Exchange (SHFE) and its subsidiary Shanghai International Energy Exchange (INE) have become the first ...

Contemporary Amperex Technology Co. Ltd., or CATL, controls more than a third of the global market for EV batteries and is ...

The IPO had raised HK$35.7 billion ($4.6 billion) according to a company filing, reportedly making it the largest global ...

Listing is expected to be the largest in Hong Kong since Kuaishou Technology raised US$6.2 billion in January 2021.

Hong Kong-traded shares in CATL, the world’s largest maker of batteries for electric vehicles, have jumped after the company ...

China's Foshan Haitian Flavouring and Food Company has received approval from the Hong Kong Stock Exchange to list in the ...

Shares of Chinese battery giant Contemporary Amperex Technology (CATL) surged as much as 3.43% on the Shenzhen Exchange on ...